Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

KILITCH DRUGS vs AUROBINDO PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    KILITCH DRUGS AUROBINDO PHARMA KILITCH DRUGS/
AUROBINDO PHARMA
 
P/E (TTM) x 49.0 23.0 213.2% View Chart
P/BV x 4.3 2.4 180.3% View Chart
Dividend Yield % 0.0 0.3 -  

Financials

 KILITCH DRUGS   AUROBINDO PHARMA
EQUITY SHARE DATA
    KILITCH DRUGS
Mar-23
AUROBINDO PHARMA
Mar-23
KILITCH DRUGS/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs218715 30.5%   
Low Rs121397 30.5%   
Sales per share (Unadj.) Rs89.6424.2 21.1%  
Earnings per share (Unadj.) Rs5.332.9 16.2%  
Cash flow per share (Unadj.) Rs7.654.1 14.0%  
Dividends per share (Unadj.) Rs03.00 0.0%  
Avg Dividend yield %00.5 0.0%  
Book value per share (Unadj.) Rs93.9458.1 20.5%  
Shares outstanding (eoy) m15.58585.94 2.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.91.3 144.6%   
Avg P/E ratio x31.916.9 189.0%  
P/CF ratio (eoy) x22.410.3 217.7%  
Price / Book Value ratio x1.81.2 149.1%  
Dividend payout %09.1 0.0%   
Avg Mkt Cap Rs m2,646325,753 0.8%   
No. of employees `000NANA-   
Total wages/salary Rs m11735,223 0.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m1,396248,554 0.6%  
Other income Rs m292,906 1.0%   
Total revenues Rs m1,425251,460 0.6%   
Gross profit Rs m17737,070 0.5%  
Depreciation Rs m3612,446 0.3%   
Interest Rs m511,405 3.6%   
Profit before tax Rs m12026,125 0.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m376,849 0.5%   
Profit after tax Rs m8319,277 0.4%  
Gross profit margin %12.714.9 85.2%  
Effective tax rate %31.126.2 118.5%   
Net profit margin %5.97.8 76.5%  
BALANCE SHEET DATA
Current assets Rs m1,264214,599 0.6%   
Current liabilities Rs m689114,938 0.6%   
Net working cap to sales %41.240.1 102.8%  
Current ratio x1.81.9 98.3%  
Inventory Days Days16321 792.5%  
Debtors Days Days1,41966 2,164.1%  
Net fixed assets Rs m911176,668 0.5%   
Share capital Rs m156586 26.6%   
"Free" reserves Rs m1,307267,813 0.5%   
Net worth Rs m1,462268,399 0.5%   
Long term debt Rs m06,190 0.0%   
Total assets Rs m2,175392,125 0.6%  
Interest coverage x3.419.6 17.2%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.60.6 101.2%   
Return on assets %6.15.3 116.5%  
Return on equity %5.77.2 78.9%  
Return on capital %11.710.0 116.6%  
Exports to sales %033.7 0.0%   
Imports to sales %015.3 0.0%   
Exports (fob) Rs mNA83,703 0.0%   
Imports (cif) Rs mNA38,060 0.0%   
Fx inflow Rs m60285,483 0.7%   
Fx outflow Rs m16141,447 0.4%   
Net fx Rs m44144,036 1.0%   
CASH FLOW
From Operations Rs m2623,868 0.1%  
From Investments Rs m79-39,778 -0.2%  
From Financial Activity Rs m-718,144 -0.0%  
Net Cashflow Rs m982,298 4.3%  

Share Holding

Indian Promoters % 69.2 48.8 142.0%  
Foreign collaborators % 0.0 3.1 -  
Indian inst/Mut Fund % 0.0 41.3 -  
FIIs % 0.0 20.7 -  
ADR/GDR % 0.0 0.0 -  
Free float % 30.8 48.2 63.9%  
Shareholders   9,062 241,944 3.7%  
Pledged promoter(s) holding % 0.0 20.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare KILITCH DRUGS With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on KILITCH DRUGS vs Aurobindo Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

KILITCH DRUGS vs Aurobindo Pharma Share Price Performance

Period KILITCH DRUGS Aurobindo Pharma S&P BSE HEALTHCARE
1-Day -0.09% 1.82% 1.18%
1-Month -3.31% 5.96% -0.75%
1-Year 172.81% 113.07% 61.82%
3-Year CAGR 68.56% 7.78% 18.16%
5-Year CAGR 14.41% 7.18% 19.79%

* Compound Annual Growth Rate

Here are more details on the KILITCH DRUGS share price and the Aurobindo Pharma share price.

Moving on to shareholding structures...

The promoters of KILITCH DRUGS hold a 69.2% stake in the company. In case of Aurobindo Pharma the stake stands at 51.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of KILITCH DRUGS and the shareholding pattern of Aurobindo Pharma.

Finally, a word on dividends...

In the most recent financial year, KILITCH DRUGS paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

Aurobindo Pharma paid Rs 3.0, and its dividend payout ratio stood at 9.1%.

You may visit here to review the dividend history of KILITCH DRUGS, and the dividend history of Aurobindo Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.